Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.65 |
| ▸ | THRB | P10828 | 1/20 | 0.65 |
| ▸ | S1PR1 | P21453 | 6/20 | 0.62 |
| ▸ | CHUK | O15111 | 1/20 | 0.57 |
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.57 |
| ▸ | NOX4 | Q9NPH5 | 1/20 | 0.57 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.56 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.56 |
| ▸ | CASP3 | P42574 | 2/20 | 0.56 |
| ▸ | S1PR3 | Q99500 | 2/20 | 0.54 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.54 |
| ▸ | RARA | P10276 | 1/20 | 0.54 |
| ▸ | RARB | P10826 | 1/20 | 0.54 |
| ▸ | RARG | P13631 | 1/20 | 0.54 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5208706 | 1.00 | LMNA (0.65) | LMNATHRBS1PR1CHUKTXNRD1 | |
| SCHEMBL19131739 | 0.89 | LMNA (0.55) | LMNATHRBS1PR1HDAC6S1PR3 | |
| SCHEMBL14106267 | 0.86 | KDM4E (0.61) | LMNATHRBS1PR1HDAC4HDAC6 | |
| SCHEMBL14149921 | 0.86 | NPC1 (0.62) | LMNATHRBS1PR1HDAC4HDAC6 | |
| SCHEMBL12171106 | 0.85 | RAB9A (0.67) | LMNAS1PR1HDAC6S1PR3SRD5A2 | |
| SCHEMBL60315 | 0.85 | NPC1 (0.63) | LMNATHRBS1PR1CHUKTXNRD1 | |
| SCHEMBL4875678 | 0.85 | NPC1 (0.63) | LMNATHRBS1PR1CHUKTXNRD1 | |
| SCHEMBL29607058 | 0.85 | NPC1 (0.63) | LMNATHRBS1PR1CHUKTXNRD1 | |
| SCHEMBL5206371 | 0.83 | MAPT (0.63) | LMNATHRBS1PR1CHUKTXNRD1 | |
| SCHEMBL11711704 | 0.83 | LMNA (0.63) | LMNATHRBS1PR1CHUKTXNRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7223791-B2 | Function regulator for retinoid relative receptor | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2007-05-29 | — | — | US | disclosed |
| US-20040157881-A1 | Function regulator for retinoid relative receptor | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2004-08-12 | — | — | US | disclosed |
| EP-1405636-A1 | FUNCTION REGULATOR FOR RETINOID RELATIVE RECEPTOR | Takeda Chemical Industries, Ltd. (JP) | 2004-04-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040157881-A1 | Function regulator for retinoid relative receptor | RXRA, RARA, RARG | LMNA 3786/4885THRB 129/4885S1PR1 1456/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.